These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 12648598)
1. Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells. Munkarah AR; Genhai Z; Morris R; Baker VV; Deppe G; Diamond MP; Saed GM Gynecol Oncol; 2003 Mar; 88(3):429-33. PubMed ID: 12648598 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells. Li M; Wu X; Xu XC Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869 [TBL] [Abstract][Full Text] [Related]
3. The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer. Munkarah AR; Ali-Fehmi R; Jiang JZ; Elhammady E; Malone JM; Saed GM Anticancer Drugs; 2007 Sep; 18(8):889-96. PubMed ID: 17667594 [TBL] [Abstract][Full Text] [Related]
4. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of chemotherapeutic drug-induced apoptosis by a cyclooxygenase-2 inhibitor in hypopharyngeal carcinoma cells. Peng JP; Liu LT; Chang HC; Hung WC Cancer Lett; 2003 Nov; 201(2):157-63. PubMed ID: 14607329 [TBL] [Abstract][Full Text] [Related]
6. Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis. Schmidt CM; Wang Y; Wiesenauer C J Gastrointest Surg; 2003 Dec; 7(8):1024-33. PubMed ID: 14675712 [TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Li M; Wu X; Xu XC Clin Cancer Res; 2001 Apr; 7(4):1010-6. PubMed ID: 11309352 [TBL] [Abstract][Full Text] [Related]
8. COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines. Honjo S; Osaki M; Ardyanto TD; Hiramatsu T; Maeta N; Ito H DNA Cell Biol; 2005 Mar; 24(3):141-7. PubMed ID: 15767780 [TBL] [Abstract][Full Text] [Related]
9. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells. Hung WC; Chang HC; Pan MR; Lee TH; Chuang LY Mol Pharmacol; 2000 Dec; 58(6):1398-403. PubMed ID: 11093779 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of NS398 on the proliferation of human ovarian cancer cell lines CAOV3 and OVCAR3 in vitro]. Wang CY; Wang M; Wang XY; Zhang SL; Wang YX; Li LK Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):415-8. PubMed ID: 12921553 [TBL] [Abstract][Full Text] [Related]
11. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells. Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells. Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells. Chang HC; Weng CF Oncol Rep; 2001; 8(6):1321-5. PubMed ID: 11605058 [TBL] [Abstract][Full Text] [Related]
14. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Liu XH; Yao S; Kirschenbaum A; Levine AC Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162 [TBL] [Abstract][Full Text] [Related]
16. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Ding XZ; Tong WG; Adrian TE Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335 [TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways. Sánchez-Alcázar JA; Bradbury DA; Pang L; Knox AJ Lung Cancer; 2003 Apr; 40(1):33-44. PubMed ID: 12660005 [TBL] [Abstract][Full Text] [Related]
18. NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2. Amirghahari N; Harrison L; Smith M; Rong X; Naumann I; Ampil F; Shi R; Glass J; Nathan CO Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1405-12. PubMed ID: 14630280 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089. Matsuo M; Yoshida N; Zaitsu M; Ishii K; Hamasaki Y J Neurooncol; 2004 Feb; 66(3):285-92. PubMed ID: 15015658 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer. Uddin S; Ahmed M; Hussain A; Assad L; Al-Dayel F; Bavi P; Al-Kuraya KS; Munkarah A Int J Cancer; 2010 Jan; 126(2):382-94. PubMed ID: 19621391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]